BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38748377)

  • 1. Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study.
    Chung WS; Wan TTH; Shiu YT; Shi HY
    J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38748377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis.
    Cressman S; Mar C; Sam J; Kan L; Lohrisch C; Spinelli JJ
    CMAJ Open; 2021; 9(2):E443-E450. PubMed ID: 33888549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway.
    Moger TA; Holen Å; Hanestad B; Hofvind S
    Pharmacoecon Open; 2022 Jul; 6(4):495-507. PubMed ID: 35796950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil.
    Couto HL; Gargano LP; de Oliveira VM; Coelho BA; Pessoa EC; Hassan AT; Silva AL; Urban LABD; Fernandes LC; Sharma N; Mann R; McIntosh SA; Zanghelini F
    Pharmacoecon Open; 2024 May; 8(3):403-416. PubMed ID: 38233699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis.
    Sankatsing VDV; Juraniec K; Grimm SE; Joore MA; Pijnappel RM; de Koning HJ; van Ravesteyn NT
    Radiology; 2020 Oct; 297(1):40-48. PubMed ID: 32749212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
    Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
    Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?
    Tollens F; Baltzer PAT; Dietzel M; Rübenthaler J; Froelich MF; Kaiser CG
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes and Cost-Effectiveness of Breast Cancer Screening With Digital Breast Tomosynthesis in the United States.
    Lowry KP; Trentham-Dietz A; Schechter CB; Alagoz O; Barlow WE; Burnside ES; Conant EF; Hampton JM; Huang H; Kerlikowske K; Lee SJ; Miglioretti DL; Sprague BL; Tosteson ANA; Yaffe MJ; Stout NK
    J Natl Cancer Inst; 2020 Jun; 112(6):582-589. PubMed ID: 31503283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital breast tomosynthesis (DBT) plus synthesised two-dimensional mammography (s2D) in breast cancer screening is associated with higher cancer detection and lower recalls compared to digital mammography (DM) alone: results of a systematic review and meta-analysis.
    Heywang-Köbrunner SH; Jänsch A; Hacker A; Weinand S; Vogelmann T
    Eur Radiol; 2022 Apr; 32(4):2301-2312. PubMed ID: 34694451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
    Pattacini P; Nitrosi A; Giorgi Rossi P; Iotti V; Ginocchi V; Ravaioli S; Vacondio R; Braglia L; Cavuto S; Campari C;
    Radiology; 2018 Aug; 288(2):375-385. PubMed ID: 29869961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System.
    Alsheik NH; Dabbous F; Pohlman SK; Troeger KM; Gliklich RE; Donadio GM; Su Z; Menon V; Conant EF
    Acad Radiol; 2019 May; 26(5):597-605. PubMed ID: 30057195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities.
    Hunter SA; Morris C; Nelson K; Snyder BJ; Poulton TB
    AJR Am J Roentgenol; 2017 May; 208(5):1171-1175. PubMed ID: 28177646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in Norway.
    Moger TA; Swanson JO; Holen ÅS; Hanestad B; Hofvind S
    Eur J Health Econ; 2019 Nov; 20(8):1261-1269. PubMed ID: 31399773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
    Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
    BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
    Blankenburg M; Sánchez-Collado I; Soyemi BO; Åkerborg Ö; Caleyachetty A; Harris J; Morris E; Newstead G; Lobig F
    J Med Econ; 2023; 26(1):850-861. PubMed ID: 37278659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the diagnostic efficacy of full field digital mammography with digital breast tomosynthesis using BIRADS score in a tertiary cancer care hospital.
    Singla D; Chaturvedi AK; Aggarwal A; Rao SA; Hazarika D; Mahawar V
    Indian J Radiol Imaging; 2018; 28(1):115-122. PubMed ID: 29692539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
    Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
    J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.